An exceptionally pricey gene therapy cure for sickle cell disease could soon be available, but it’s not clear whether insurance companies will balk at the cost and deny coverage. On the surface, the gene therapy does not appear as cost-effective as the grinding medical care that sickle cell patients now receive, according to a new… read on > read on >
All Health and Wellness:
Men’s Mental Health: Symptoms, Treatments & Where to Find Help
When it comes to mental health, men don’t always seek help when they need it. But maybe they should. June is Men’s Mental Health Month, so here are the most common mental health conditions men experience, the symptoms that may differ in men vs. women and what resources are available for those seeking treatment options.… read on > read on >
Mind-Body Effects of Qigong Might Help Ease Cancer-Related Fatigue
When the late Brown University researcher Catherine Kerr had cancer, she benefited from an ancient Chinese practice known as qigong and began looking into its impact on others. Now, her colleagues are building on Kerr’s work, studying how practicing qigong affects a person’s perception of fatigue in a small group of 24 female cancer patients… read on > read on >
AHA News: 38-Year-Old Has Had 3 Hearts: ‘It’s a Third Chance’
WEDNESDAY, May 31, 2023 (American Heart Association News) — Melanie Wickersheim has no memory of the first time her heart gave her trouble. She was an infant, and her pediatric myocarditis – an inflammation of the muscular walls of the heart – resolved before she was old enough to know anything had ever been wrong.… read on > read on >
Low-Dose Colchicine Might Prevent or Delay Knee, Hip Replacements
An anti-inflammatory drug that has been around for over 2,000 years might help delay a very modern problem: hip and knee replacements. That’s the suggestion of a new study finding that older adults who used the drug — called colchicine — were less likely to need hip or knee replacement surgery over the next two… read on > read on >
Long COVID Can Make It Tougher to Exercise, and Research Is Revealing Why
Lack of energy for exercise is a common problem for folks with so-called long COVID. New research pinpoints the most likely reason why: diminished capacity to get the heart pumping fast enough to support the effort. The name for this is chronotropic incompetence. “The amount of aerobic exercise an individual can do is limited largely… read on > read on >
Ketamine Nasal Spray Could Be New Treatment for Migraines
A nasal spray containing ketamine might help relieve migraine headaches when other treatments fail, a new study suggests. Ketamine is a synthetic anesthetic with hallucinogenic effects that is sometimes used intravenously for migraine headaches. It’s being tried for treatment-resistant depression, too. But it’s also a potentially addictive “party” drug so it is not for everyone.… read on > read on >
FDA Issues Warning About Compounded Versions of Wegovy, Ozempic
(HealthDay News) – Patients taking semaglutide for type 2 diabetes or weight loss should be careful about where they’re getting the medication, the U.S. Food and Drug Administration warned Tuesday. Shortages of the drug, commonly sold as Wegovy and Ozempic, has led to the making of compounded versions of the drugs, which is combining or… read on > read on >
Sick Restaurant Workers Fuel Many Foodborne Illness Outbreaks
(HealthDay News) – Providing sick leave to restaurant workers could help prevent the spread of foodborne illness because ill workers are key drivers of outbreaks at restaurants, a new government report shows. The U.S. Centers for Disease Control and Prevention published data on Tuesday covering 800 outbreaks of foodborne illness at restaurants between 2017 and… read on > read on >
The Arch of the Human Foot Was Key to Upright Walking, Scientists Say
That happy, confident spring in your step is likely a benefit imparted by human evolution, a new study argues. Humans may have evolved a spring-like arch in our feet to help us better walk and run upright, researchers say in their study, published May 30 in the journal Frontiers in Bioengineering and Biotechnology. It’s long… read on > read on >